Disrupting protein quality control slows tumor growth in pediatric rhabdomyosarcoma
A new research paper was published in Volume 16 of Oncotarget on August 29, 2025, titled “In vivo manipulation of the…
ATOX1 drives hepatocellular carcinoma progression through c-Myb and PI3K/AKT activation
Background and aims Despite advancements in diagnostic and therapeutic strategies, hepatocellular carcinoma (HCC) remains a leading cause of…